ABSTRACT
The aim of this pilot study was to evaluate pre-emptive analgesia using the combination tramadol plus meloxicam compared with each individual drug alone for the reduction of pain after extraction of third molars. Fifty-one patients were randomised into three groups (n=17 in each), using a series of random numbers: the first group was given tramadol 25mg and meloxicam 7.5mg; the second tramadol 50mg, and the third meloxicam 15 mg, all intramuscularly. Treatments were prepared in identical syringes by an independent investigator and were given immediately. The teeth were removed 50 min after the analgesics had been given. Intensity of pain, consumption of analgesics, and adverse effects were evaluated. The intensity of pain was evaluated using a visual analogue scale (VAS) and the area under the curve of the VAS showed significant differences amongst the groups. In conclusion, the study showed that the combination of tramadol 25mg and meloxicam 7.5mg had an analgesic effect similar to that of meloxicam 15 mg, but both were better than tramadol 50mg for relief of pain after the extraction of mandibular third molars.
Subject(s)
Analgesics, Opioid/therapeutic use , Anti-Inflammatory Agents/pharmacology , Molar, Third/surgery , Pain, Postoperative/drug therapy , Thiazines/therapeutic use , Thiazoles/therapeutic use , Tramadol/therapeutic use , Adolescent , Adult , Analysis of Variance , Area Under Curve , Double-Blind Method , Drug Combinations , Female , Humans , Male , Meloxicam , Pain Measurement , Pilot ProjectsABSTRACT
PURPOSE: To compare the pre-emptive analgesic effectiveness of 15 mg of meloxicam and 50 mg of tramadol after mandibular third molar surgery. PATIENTS AND METHODS: This pilot study was a double-blind, randomized, parallel-group clinical trial. The patients were randomized into 2 treatment groups, each with 15 patients, by use of a series of random numbers: group A was administered 15 mg of meloxicam intramuscularly (IM) 50 minutes before the surgery and group B was given 50 mg of tramadol IM 50 minutes before the surgery. We evaluated pain intensity, analgesic consumption, swelling, and trismus. RESULTS: The group receiving 15 mg of meloxicam IM showed differences in pain intensity evaluated by the area under the curve of the visual analog scale and total analgesic consumption when compared with the group receiving 50 mg of tramadol IM. CONCLUSION: The patients receiving 15 mg of preoperative meloxicam had less pain intensity and total analgesic consumption than those receiving 50 mg of preoperative tramadol.
Subject(s)
Analgesics, Opioid/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Mandible/surgery , Molar, Third/surgery , Premedication , Thiazines/therapeutic use , Thiazoles/therapeutic use , Tooth Extraction/methods , Tramadol/therapeutic use , Adolescent , Adult , Double-Blind Method , Edema/etiology , Female , Humans , Injections, Intramuscular , Ketorolac/therapeutic use , Male , Meloxicam , Pain Measurement , Pain, Postoperative/prevention & control , Pilot Projects , Postoperative Complications , Time Factors , Tooth, Impacted/surgery , Trismus/etiology , Young AdultABSTRACT
Synovial Chondromatosis (SC) is a disease whose etiology is unknown, can be defined as a benign synovial process characterized by the formation of metaplastic cartilaginous nodes inside connective tissue of articular surfaces, is considered an active metaplastic phenomenon better than a neoplastic process; it presents a greater preference to affect women who constitute almost 70% of reported cases, the age range is wide and oscillates between 18-75 years (average 44.6 years). Between the main clinical findings are: pain, crackle, volume augmentation and a limited buccal opening. SC is an unusual state and the reports in the English literature are no more than 75 cases, only 66 of those where histologically verified, most of those were affecting great joints like hip, knee and shoulder, but if SC is not frequent in this sites, is even more infrequent on temporomandibular joint. The aim of this paper is to report a clinical case and at the same time to realize a brief review of the literature.
Subject(s)
Chondromatosis, Synovial , Temporomandibular Joint Disorders , Chondromatosis, Synovial/diagnosis , Chondromatosis, Synovial/surgery , Female , Humans , Middle Aged , Temporomandibular Joint Disorders/diagnosis , Temporomandibular Joint Disorders/surgeryABSTRACT
La condromatosis sinovial (CS) es una enfermedad de etiología desconocida, la cual pude definirse como un proceso benigno sinovial caracterizado por la formación de nódulos cartilaginosos metaplásicos dentro del tejido conectivo de las superficies articulares, se le considera un fenómeno metaplásico activo más que un proceso neoplásico; presenta una marcada preferencia por afectar a mujeres constituyendo casi el 70 por ciento de los casos reportados, el rango de edad es amplio y oscila entre los 18 y 75 años con una media de 44.6 años. Dentro de los principales hallazgos clínicos destacan: sintomatología dolorosa, presencia de crepitación, aumento de volumen y limitación de la apertura bucal. La CS es una entidad poco frecuente de la cual se han reportado no más de 75 casos en la literatura inglesa, sólo 66 de ellos comprobados histológicamente, la mayoría afectando principalmente grandes articulaciones como cadera, rodilla y hombro; pero si la frecuencia es rara en estas localizaciones, lo es más aún en la articulación temporomandibular. El objetivo del presente artículo es el de reportar un caso clínico a la vez que se realiza una breve revisión de la literatura
Synovial Chondromatosis (SC) is a disease whose etiology is unknown, can be defined as a benign synovial process characterized by the formation of metaplastic cartilaginous nodes inside connective tissue of articular surfaces, is considered an active metaplastic phenomenon better than a neoplastic process; it presents a greater preference to affect women who constitute almost 70 percents of reported cases, the age range is wide and oscillates between 18 - 75 years (average 44.6 years). Between the main clinical findings are: pain, crackle, volume augmentation and a limited buccal opening. SC is an unusual state and the reports in the English literature are no more than 75 cases, only 66 of those where histologically verified, most of those were affecting great joints like hip, knee and shoulder, but if SC is not frequent in this sites, is even more infrequent on temporomandibular joint. The aim of this paper is to report a clinical case and at the same time to realize a brief review of the literature
Subject(s)
Female , Middle Aged , Humans , Chondromatosis, Synovial/diagnosis , Temporomandibular Joint Disorders/diagnosis , Temporomandibular Joint Disorders/surgery , Chondromatosis, Synovial/surgeryABSTRACT
Se realizó un análisis retrospectivo de 15 pacientes con fracturas mandibulares por proyectil de arma de fuego. La tendencia fue llevar a cabo un tratamiento conservador incluyendo debridación, irrigación, fijación interdentomaxilar, protección antimicrobiana y fisioterapia postoperatoria. Estos traumatismos ameritan manejo multidisciplinario, donde se incluye la cirugía maxilofacial
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Fracture Fixation/methods , Mandibular Fractures/epidemiology , Mandibular Fractures/therapy , Wounds, Gunshot/rehabilitation , Wounds, Gunshot/therapy , Physical Therapy SpecialtyABSTRACT
Se presenta un estudio clínico para valorar el efecto terapéutico del silicón, aplicado en forma de lámina de gel, sobre cicatrices hipertróficas y queloides. Se reporta mejoría en los 10 casos tratados, tanto en las características clínicas de las lesiones, como en la sintomatología referida. El promedio de reducción de las cicatrices en este estudio fue del 40 por ciento. Se hace énfasis en la importancia de la responsabilidad del paciente en el manejo del medicamento, así como de su cooperación para el éxito del procedimiento
